Adeboye Adejare

University of the Sciences in Philadelphia, USA

Lecture Title:

“Strategies for re-discovery of CNS drugs from African plants”

ADEBOYE ADEJARE

Professor, Department of Pharmaceutical Sciences; Philadelphia College of Pharmacy (PCP); Research Professor, Department of Chemistry and Biochemistry University of the Sciences in Philadelphia (USciences); Philadelphia, PA 83209-8334 Phone: (215) 596-8944 Fax: (215) 895-1161; Email: a.adejar@usciences.edu Website: https://faculty.usciences.edu/faculty/adejare-adeboye

Dr. Adeboye Adejare received BS (1978) and MS (1980) in Chemistry from University of Iowa followed by Ph.D. in Medicinal Chemistry from The Ohio State University (1985). He did postdoctoral studies at the National Institutes of Health (NIH) for 3 years prior to beginning career in academia. He is currently Professor of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. His research is geared towards discovery of novel compounds that can be used to probe mechanisms and for treatment of neurodegeneration as observed in Alzheimer’s disease and related disorders, anti-cancer drug discovery, pharmaceutical profiling, and drug targeting. His research was/is funded by the Commonwealth of Pennsylvania, NIH, the Office of Naval Research, and several pharmaceutical companies. These efforts have resulted in over 50 publications, 5 patents and over 100 presentations at national and international conferences. Many students from his group have received graduate degrees (MS and Ph.D.) and are employed in academia and the pharmaceutical industry. He has also served as mentor to several postdoctoral associates, MacArthur and Fulbright Fellows, as well as visiting faculty members. He was selected for the inaugural class of Carnegie Foundation/Corporation African Diaspora Fellowship Program, 2014 (at University of Ibadan, Nigeria); and also in 2019 (at University of Lagos, Nigeria). He is recipient of many awards. Dr. Adejare served/serves on several national panels, including grant review panels for NIH, National Science Foundation, National Academy of Science, and Alzheimer’s Association. He is Editor-in-Chief, Remington: The Science and Practice of Pharmacy; and Editor for section on Pharmaceutical Chemistry. He is also editor of book titled Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease (Elsevier).